A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin [sirolimus] in Men With Advanced Localized Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Sirolimus (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 14 Apr 2009 Planned number of patients changed from 42 to 60 as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.